絞り込み

16532

広告

The risk of acute kidney injury in Asians treated with apixaban, rivaroxaban, dabigatran, or warfarin for non-valvular atrial fibrillation: A nationwide cohort study in Taiwan.

著者 Chan YH , Yeh YH , Hsieh MY , Chang CY , Tu HT , Chang SH , See LC , Kuo CF , Kuo CT
Int J Cardiol.2018 Aug 15 ; 265():83-89.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (28view , 0users)

Full Text Sources

Whether or not non-vitamin K antagonist oral anticoagulants (NOACs) are associated with a lower risk of acute kidney injury (AKI) in patients with non-valvular atrial fibrillation (NVAF) remains unknown in real world practice.
PMID: 29885705 [PubMed - in process]
印刷用ページを開く Endnote用テキストダウンロード